CAPELLA: LEN in MDR HIV at Wk 104
CAPELLA: Wk 104 Results With Long-Acting Subcutaneous Lenacapavir in Persons Living With Multidrug-Resistant HIV

Released: October 19, 2023

Activity

Progress
1
Course Completed